Statistics
Publications
4
Citations
99
H-Index
4
Active since
2005
Luxia Xu is an author at Shanghai Institutes for Biological Sciences specializing in molecular biology, life sciences, and tumor immunology.
Publications per year
2005–2024
4
4
Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma
Feng Ji, Luxia Xu, Kaili Long et al. · Translational research · 2023 · 21 citations
Medicine, Cancer Biology, Immunology +11
TIPE2: A Candidate for Targeting Antitumor Immunotherapy
Luxia Xu, Feiyan Pan, Zhigang Guo · The Journal of Immunology · 2024 · 11 citations
Life Sciences, Immunology, Oncology +13
1–4 of 4